Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
- 1 September 2013
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 19 (17), 4685-4696
- https://doi.org/10.1158/1078-0432.ccr-12-2549
Abstract
Background: Inflammatory breast cancer (IBC) is a poorly characterized form of breast cancer. So far, the results of expression profiling in IBC are inconclusive due to various reasons including limited sample size. Here, we present the integration of three Affymetrix expression datasets collected through the World IBC Consortium allowing us to interrogate the molecular profile of IBC using the largest series of IBC samples ever reported. Experimental Design: Affymetrix profiles (HGU133-series) from 137 patients with IBC and 252 patients with non-IBC (nIBC) were analyzed using unsupervised and supervised techniques. Samples were classified according to the molecular subtypes using the PAM50-algorithm. Regression models were used to delineate IBC-specific and molecular subtype-independent changes in gene expression, pathway, and transcription factor activation. Results: Four robust IBC-sample clusters were identified, associated with the different molecular subtypes (P < 0.001), all of which were identified in IBC with a similar prevalence as in nIBC, except for the luminal A subtype (19% vs. 42%; P < 0.001) and the HER2-enriched subtype (22% vs. 9%; P < 0.001). Supervised analysis identified and validated an IBC-specific, molecular subtype-independent 79-gene signature, which held independent prognostic value in a series of 871 nIBCs. Functional analysis revealed attenuated TGF-β signaling in IBC. Conclusion: We show that IBC is transcriptionally heterogeneous and that all molecular subtypes described in nIBC are detectable in IBC, albeit with a different frequency. The molecular profile of IBC, bearing molecular traits of aggressive breast tumor biology, shows attenuation of TGF-β signaling, potentially explaining the metastatic potential of IBC tumor cells in an unexpected manner. Clin Cancer Res; 19(17); 4685–96. ©2013 AACR.Keywords
Other Versions
This publication has 37 references indexed in Scilit:
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJCI Insight, 2011
- Array-Based DNA Methylation Profiling for Breast Cancer Subtype DiscriminationPLOS ONE, 2010
- PhosphoMARCKS drives motility of mouse melanoma cellsCellular Signalling, 2010
- A pathway-based classification of human breast cancerProceedings of the National Academy of Sciences, 2010
- NF-kappa B genes have a major role in Inflammatory Breast CancerBMC Cancer, 2008
- A stromal gene signature associated with inflammatory breast cancerInternational Journal of Cancer, 2007
- Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profilingBreast Cancer Research and Treatment, 2005
- Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast CancerCancer Research, 2005
- Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasisMutation Research, 2004
- Persistent E-Cadherin Expression in Inflammatory Breast CancerLaboratory Investigation, 2001